Genome-wide views of cancer metastasis

Drug Discovery Today: Disease Mechanisms

Volumn 2, Issue 2, 2005, Pages 165-169

  Wadlow, Raymond ^a   Finley, S Aidan ^a   Ramaswamy, Sridhar ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BETA ACTIN; BETA CATENIN; CONNECTIVE TISSUE GROWTH FACTOR; EPIDERMAL GROWTH FACTOR; ESTROGEN RECEPTOR; FRIZZLED PROTEIN; INTERLEUKIN 11; MATRIX METALLOPROTEINASE INHIBITOR; PROTEIN KINASE C; RAS PROTEIN; SCATTER FACTOR RECEPTOR; TRANSCRIPTION FACTOR TWIST; UVOMORULIN; WNT PROTEIN;

BONE METASTASIS; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER INVASION; CARCINOGENESIS; CLINICAL TRIAL; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE MUTATION; GENETIC ASSOCIATION; GENETIC MARKER; HUMAN; INCIDENCE; LUNG METASTASIS; MALIGNANT TRANSFORMATION; METASTASIS; MOLECULAR MECHANICS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PREDICTION; PROGNOSIS; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; SOLID TUMOR;

EID: 33645080925     PISSN: 17406765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmec.2005.05.026     Document Type: Review

References (33)

1. D.M. Parkin et. al. Global cancer statistics CA Cancer J. Clin. 55 2002 74-108
2. S. Hellman et. al. Cancer: Principles and Practice of Oncology 2005 Lippincott-Raven
3. J.C. Bailar III H.L. Gornik Cancer undefeated N. Engl. J. Med. 336 1997 1569-1574
4. L.A. Liotta E.C. Kohn The microenvironment of the tumour-host interface Nature 411 2001 375-379
5. J.P. Thiery Epithelial-mesenchymal transitions in tumour progression Nat. Rev. Cancer 2 2002 442-454
6. S. Ramaswamy T.R. Golub DNA microarrays in clinical oncology J. Clin. Oncol. 20 2002 1932-1941
7. R.A. Young Biomedical discovery with DNA arrays Cell 102 2000 9-15
8. G. Poste I.J. Fidler The pathogenesis of cancer metastasis Nature 283 1980 139-146
9. S.E. Egan et. al. Transformation by oncogenes encoding protein kinases induces the metastatic phenotype Science 238 1987 202-205
10. K.A. Furge et. al. Suppression of Ras-mediated tumorigenicity and metastasis through inhibition of the Met receptor tyrosine kinase Proc. Natl. Acad. Sci. USA 98 2001 10722-10727
11. A.I. McClatchey et. al. Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors Genes Dev. 12 1998 1121-1133
12. S. Braun et. al. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer N. Engl. J. Med. 342 2000 525-533
13. O. Schmidt-Kittler et. al. From latent disseminated cells to overt metastasis: Genetic analysis of systemic breast cancer progression Proc. Natl. Acad. Sci. USA 100 2003 7737-7742
14. O. Solakoglu et. al. Heterogeneous proliferative potential of occult metastatic cells in bone marrow of patients with solid epithelial tumors Proc. Natl. Acad. Sci. USA 99 2002 2246-2251
15. L.J. van't Veer et. al. Gene expression profiling predicts clinical outcome of breast cancer Nature 415 2002 530-536
16. M.J. van de Vijver et. al. A gene-expression signature as a predictor of survival in breast cancer N. Engl. J. Med. 347 2002 1999-2009
17. S. Ramaswamy et. al. A molecular signature of metastasis in primary solid tumors Nat. Genet. 33 2003 49-54
18. R.O. Hynes Metastatic potential: Generic predisposition of the primary tumor or rare, metastatic variants or both? Cell 113 2003 821-823
19. Y. Kang et. al. A multigenic program mediating breast cancer metastasis to bone Cancer Cell 3 2003 537-549
20. T.H. Qiu et. al. Global expression profiling identifies signatures of tumor virulence in MMTV-PyMT-transgenic mice: Correlation to human disease Cancer Res. 64 2004 5973-5981
21. M. Bittner et. al. Molecular classification of cutaneous malignant melanoma by gene expression profiling Nature 406 2000 536-540
22. A.T. Weeraratna et. al. Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma Cancer Cell 1 2002 279-288
23. J. Szalay et. al. Associations of PKC isoforms with the cytoskeleton of B16F10 melanoma cells J. Histochem. Cytochem. 49 2001 49-66
24. E.A. Clark et. al. Genomic analysis of metastasis reveals an essential role for RhoC Nature 406 2000 532-535
25. T. Ikoma et. al. A definitive role of RhoC in metastasis of orthotopic lung cancer in mice Clin. Cancer Res. 10 2004 1192-1200
26. C.G. Kleer et. al. Characterization of RhoC expression in benign and malignant breast disease: A potential new marker for small breast carcinomas with metastatic ability Am. J. Pathol. 160 2002 579-584
27. J. Yang et. al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis Cell 117 2004 927-939
28. C.J. Aslakson F.R. Miller Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor Cancer Res. 52 1992 1399-1405
29. W. Wang et. al. Single cell behavior in metastatic primary mammary tumors correlated with gene expression patterns revealed by molecular profiling Cancer Res. 62 2002 6278-6288
30. W. Wang et. al. Identification and testing of a gene expression signature of invasive carcinoma cells within primary mammary tumors Cancer Res. 64 2004 8585-8594
31. S. Paget The distribution of secondary growths in cancer of the breast Lancet 1 1889 571-573
32. S.R. Bramhall et. al. Marimastat as first-line therapy for patients with unresectable pancreatic cancer: A randomized trial J. Clin. Oncol. 19 2001 3447-3455
33. P.D. Brown Ongoing trials with matrix metalloproteinase inhibitors Expert Opin. Invest. Drugs. 9 2000 2167-2177